{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:29:03Z","timestamp":1786422543530,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07247-0","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:59:38Z","timestamp":1784199578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term clinical outcomes of neonatal cystic fibrosis presentation: a single-center retrospective study"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1884-1090","authenticated-orcid":false,"given":"Ema","family":"Freitas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4251-3560","authenticated-orcid":false,"given":"Carolina","family":"Sim\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2407-6005","authenticated-orcid":false,"given":"Raquel Lopes","family":"de Bragan\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0762-7730","authenticated-orcid":false,"given":"Susana","family":"Castanhinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"7247_CR1","unstructured":"Orphanet (2020) Cystic fibrosis. Available at: https:\/\/www.orpha.net\/en\/disease\/detail\/586. Accessed 15 May 2026"},{"issue":"3","key":"7247_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijns4030022","volume":"4","author":"A Marc\u00e3o","year":"2018","unstructured":"Marc\u00e3o A, Barreto C, Pereira L, Vaz LG, Cavaco J, Casimiro A, F\u00e9lix M, Silva TR, Barbosa T, Freitas C, Nunes S, Fel\u00edcio V, Lopes L, Amaral M, Vilarinho L (2018) Cystic fibrosis newborn screening in Portugal: PAP value in populations with stringent rules for genetic studies. Int J Neonatal Screen 4(3):22. https:\/\/doi.org\/10.3390\/ijns4030022","journal-title":"Int J Neonatal Screen"},{"key":"7247_CR3","unstructured":"Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge (n.d.) Programa Nacional de Diagn\u00f3stico Precoce. Minist\u00e9rio da Sa\u00fade. Available at: https:\/\/www.insa.min-saude.pt\/category\/areas-de-atuacao\/genetica-humana\/programa-nacional-de-diagnostico-precoce\/. Accessed 15 May 2026"},{"issue":"3","key":"7247_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/ijns11030069","volume":"11","author":"B Camacho","year":"2025","unstructured":"Camacho B, Pereira L, Bragan\u00e7a R et al (2025) Evaluating the impact of newborn screening for cystic fibrosis in Portugal: a decade of insights and outcomes. Int J Neonatal Screen 11(3):69. https:\/\/doi.org\/10.3390\/ijns11030069","journal-title":"Int J Neonatal Screen"},{"issue":"10","key":"7247_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1542\/pir.2019-0212","volume":"41","author":"AC Miller","year":"2020","unstructured":"Miller AC, Comellas AP (2020) Cystic fibrosis. Pediatr Rev 41(10):500\u2013512. https:\/\/doi.org\/10.1542\/pir.2019-0212","journal-title":"Pediatr Rev"},{"key":"7247_CR6","unstructured":"Dire\u00e7\u00e3o-Geral da Sa\u00fade (2015) Diagn\u00f3stico da fi brose qu\u00edstica em idade pedi\u00e1trica e no adulto. Norma n.\u00ba 031\/2012, atualizada em 30 Jul 2015. Dire\u00e7\u00e3o-Geral da Sa\u00fade, Lisboa. Available at: https:\/\/normas.dgs.min-saude.pt\/wp-content\/uploads\/2019\/12\/diagnostico-da-fibrose-quistica-em-idade-pediatrica-e-no-adulto.pdf. Accessed 14 Jul 2026"},{"issue":"2","key":"7247_CR7","doi-asserted-by":"publisher","first-page":"2200951","DOI":"10.1183\/13993003.00951-2022","volume":"61","author":"R Buzzetti","year":"2023","unstructured":"Buzzetti R, Baldo E, Forneris MP et al (2023) Real-world outcomes in cystic fibrosis in the era of highly effective CFTR modulators: registry-based evidence. Eur Respir J 61(2):2200951. https:\/\/doi.org\/10.1183\/13993003.00951-2022","journal-title":"Eur Respir J"},{"issue":"4","key":"7247_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S2213-2600(22)00402-7","volume":"11","author":"PR Burgel","year":"2023","unstructured":"Burgel PR, Munck A, Durieu I et al (2023) Impact of elexacaftor\/tezacaftor\/ivacaftor on disease progression in cystic fibrosis: real-world data. Lancet Respir Med 11(4):321\u2013332. https:\/\/doi.org\/10.1016\/S2213-2600(22)00402-7","journal-title":"Lancet Respir Med"},{"issue":"10","key":"7247_CR9","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1513\/AnnalsATS.202201-041OC","volume":"19","author":"N Volkova","year":"2022","unstructured":"Volkova N, Moy K, Evans J et al (2022) Disease progression in patients with cystic fibrosis treated with CFTR modulators: registry analysis. Ann Am Thorac Soc 19(10):1652\u20131660. https:\/\/doi.org\/10.1513\/AnnalsATS.202201-041OC","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"7247_CR10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jcf.2022.11.001","volume":"22","author":"C Castellani","year":"2023","unstructured":"Castellani C, Duff AJA, Bell SC et al (2023) ECFS best practice guidelines: the 2023 update on cystic fibrosis care. J Cyst Fibros 22(1):S1\u2013S30. https:\/\/doi.org\/10.1016\/j.jcf.2022.11.001","journal-title":"J Cyst Fibros"},{"issue":"9","key":"7247_CR11","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1056\/NEJMra2201684","volume":"387","author":"CY Ooi","year":"2022","unstructured":"Ooi CY, Ramsey BW, McKone EF (2022) Long-term outcomes of highly effective CFTR modulator therapy in cystic fibrosis. N Engl J Med 387(9):834\u2013845. https:\/\/doi.org\/10.1056\/NEJMra2201684","journal-title":"N Engl J Med"},{"issue":"3","key":"7247_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1164\/rccm.202201-0123OC","volume":"206","author":"M Rosenfeld","year":"2022","unstructured":"Rosenfeld M, Wainwright CE, Higgins M et al (2022) Pulmonary outcomes in children with cystic fibrosis in the CFTR modulator era. Am J Respir Crit Care Med 206(3):287\u2013296. https:\/\/doi.org\/10.1164\/rccm.202201-0123OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"7247_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S2352-4642(23)00245-8","volume":"8","author":"KA McBennett","year":"2024","unstructured":"McBennett KA, Davies JC (2024) Early life disease in cystic fibrosis: implications of newborn screening and early intervention. Lancet Child Adolesc Health 8(1):12\u201324. https:\/\/doi.org\/10.1016\/S2352-4642(23)00245-8","journal-title":"Lancet Child Adolesc Health"},{"key":"7247_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jpeds.2022.02.012","volume":"245","author":"SZ Nasr","year":"2022","unstructured":"Nasr SZ, Quittner AL, McCoy KS et al (2022) Real-world effectiveness of CFTR modulators in children with cystic fibrosis. J Pediatr 245:20-28.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2022.02.012","journal-title":"J Pediatr"},{"issue":"1","key":"7247_CR15","doi-asserted-by":"publisher","first-page":"2300987","DOI":"10.1183\/13993003.00987-2023","volume":"63","author":"K De Boeck","year":"2024","unstructured":"De Boeck K, Zolin A, Viviani L et al (2024) Changing epidemiology and survival in cystic fibrosis in Europe. Eur Respir J 63(1):2300987. https:\/\/doi.org\/10.1183\/13993003.00987-2023","journal-title":"Eur Respir J"},{"issue":"12","key":"7247_CR16","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1136\/thoraxjnl-2022-219345","volume":"77","author":"SL Heltshe","year":"2022","unstructured":"Heltshe SL, VanDevanter DR, Skalland M et al (2022) Longitudinal lung function trajectories in the CFTR modulator era. Thorax 77(12):1180\u20131188. https:\/\/doi.org\/10.1136\/thoraxjnl-2022-219345","journal-title":"Thorax"},{"issue":"2","key":"7247_CR17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jcf.2026.02.010","volume":"25","author":"ST Pallenberg","year":"2026","unstructured":"Pallenberg ST, Zamarr\u00f3n de Lucas E, P\u00e1rniczky A, Lopes de Bragan\u00e7a R (2026) Cystic fibrosis year in review 2025. J Cyst Fibros 25(2):198\u2013203. https:\/\/doi.org\/10.1016\/j.jcf.2026.02.010","journal-title":"J Cyst Fibros"},{"issue":"3","key":"7247_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jcf.2024.03.012","volume":"23","author":"M Higgins","year":"2024","unstructured":"Higgins M, Liu M, Lu J, Rodriguez-Romero V, Shih JL, Rosenfeld M, VX15-770-124 Study Group (2024) Safety and efficacy of ivacaftor in infants aged 1 to less than 4 months with cystic fibrosis. J Cyst Fibros 23(3):429\u2013435. https:\/\/doi.org\/10.1016\/j.jcf.2024.03.012","journal-title":"J Cyst Fibros"},{"issue":"4","key":"7247_CR19","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jcf.2022.04.005","volume":"21","author":"S Szentpetery","year":"2022","unstructured":"Szentpetery S, Foil K, Hendrix S, Gray S, Mingora C, Head B, Johnson D, Flume PA (2022) A case report of CFTR modulator administration via carrier mother to treat meconium ileus in a F508del homozygous fetus. J Cyst Fibros 21(4):721\u2013724. https:\/\/doi.org\/10.1016\/j.jcf.2022.04.005","journal-title":"J Cyst Fibros"},{"issue":"7","key":"7247_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15072625","volume":"15","author":"A Boni","year":"2026","unstructured":"Boni A, Vassallo C, Ciciriello F, Cristiani L, Mancini A, Zucaro L, Graziano S, Goffredo BM, Alghisi F, Raponi M, Fabietti I, On Behalf Of Opbg Cf Pregnancy And Fetal Therapy Multidisciplinary Group (2026) Prenatal Elexacaftor\/Tezacaftor\/Ivacaftor for fetal meconium ileus: first Italian case and narrative overview of the emerging evidence. J Clin Med 15(7):2625. https:\/\/doi.org\/10.3390\/jcm15072625","journal-title":"J Clin Med"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07247-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07247-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07247-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:50:13Z","timestamp":1786420213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07247-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":20,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["7247"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07247-0","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"26 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective observational study was conducted in accordance with the Declaration of Helsinki. Ethics committee review was requested from the Ethics Committee of ULS S\u00e3o Jos\u00e9 and was pending at the time of manuscript submission.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"582"}}